Memory Pharmaceuticals (MEMY) to Present at the Rodman & Renshaw Annual Global Investment Conference  
11/7/2008 8:51:15 AM

MONTVALE, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. today announced that Michael Smith, Chief Financial Officer and Head of Business Development, will provide a company update at the Rodman & Renshaw Annual Global Investment Conference on Tuesday, November 11, 2008 at 11:10 a.m. EST at the New York Palace Hotel, in New York City.

Interested parties may access the live webcast of the presentation by visiting the "Investors" section of Memory Pharmaceuticals' website at Archived versions of the webcast will be available at the same location for one week following the presentation.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and schizophrenia. For additional information, please visit our website at

CONTACT: Jzaneen Lalani, General Counsel of Memory Pharmaceuticals Corp.,
+1-201-802-7249; or Laura Perry of LMP Investor Relations Inc.,
+1-646-719-1055, of Memory Pharmaceuticals Corp.

Web site: